195 related articles for article (PubMed ID: 25454460)
1. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.
Wahyuni TS; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Fuchino H; Kawahara N; Hayashi Y; Aoki C; Hotta H
Fitoterapia; 2014 Dec; 99():276-83. PubMed ID: 25454460
[TBL] [Abstract][Full Text] [Related]
2. Chalepin: isolated from Ruta angustifolia L. Pers induces mitochondrial mediated apoptosis in lung carcinoma cells.
Richardson JS; Sethi G; Lee GS; Malek SN
BMC Complement Altern Med; 2016 Oct; 16(1):389. PubMed ID: 27729078
[TBL] [Abstract][Full Text] [Related]
3. Semisynthesis of (-)-Rutamarin Derivatives and Their Inhibitory Activity on Epstein-Barr Virus Lytic Replication.
Lin Y; Wang Q; Gu Q; Zhang H; Jiang C; Hu J; Wang Y; Yan Y; Xu J
J Nat Prod; 2017 Jan; 80(1):53-60. PubMed ID: 28093914
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.
Wahyuni TS; Tumewu L; Permanasari AA; Apriani E; Adianti M; Rahman A; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Nasronudin ; Fuchino H; Kawahara N; Shoji I; Deng L; Aoki C; Hotta H
Virol J; 2013 Aug; 10():259. PubMed ID: 24089993
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor.
Wahyuni TS; Mahfud H; Permatasari AA; Widyawaruyanti A; Fuad A
J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837259
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus.
Ratnoglik SL; Aoki C; Sudarmono P; Komoto M; Deng L; Shoji I; Fuchino H; Kawahara N; Hotta H
Microbiol Immunol; 2014 Mar; 58(3):188-94. PubMed ID: 24438164
[TBL] [Abstract][Full Text] [Related]
7. Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential.
Nahar L; Al-Majmaie S; Al-Groshi A; Rasul A; Sarker SD
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799365
[TBL] [Abstract][Full Text] [Related]
8. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis C virus replication by antimonial compounds.
Hwang DR; Lin RK; Leu GZ; Lin TY; Lien TW; Yu MC; Yeh CT; Hsu JT
Antimicrob Agents Chemother; 2005 Oct; 49(10):4197-202. PubMed ID: 16189098
[TBL] [Abstract][Full Text] [Related]
11. Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation.
Wohl BM; Smith AA; Jensen BE; Zelikin AN
J Control Release; 2014 Dec; 196():197-207. PubMed ID: 25451544
[TBL] [Abstract][Full Text] [Related]
12. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
[TBL] [Abstract][Full Text] [Related]
13. Anti-MRSA Constituents from
Al-Majmaie S; Nahar L; Rahman MM; Nath S; Saha P; Talukdar AD; Sharples GP; Sarker SD
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669881
[No Abstract] [Full Text] [Related]
14. Hepatitis C virus inhibitory hydrolysable tannins from the fruits of Terminalia chebula.
Ajala OS; Jukov A; Ma CM
Fitoterapia; 2014 Dec; 99():117-23. PubMed ID: 25261266
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of hepatitis C virus (HCV) replication - implications for the development of antiviral drugs].
Bühler S; Bartenschlager R
Z Gastroenterol; 2011 Jul; 49(7):836-44. PubMed ID: 21766263
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hepatitis C virus replication by cyclin-dependent kinase inhibitors.
Munakata T; Inada M; Tokunaga Y; Wakita T; Kohara M; Nomoto A
Antiviral Res; 2014 Aug; 108():79-87. PubMed ID: 24893207
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2.
Lee JC; Chen WC; Wu SF; Tseng CK; Chiou CY; Chang FR; Hsu SH; Wu YC
Antiviral Res; 2011 Jan; 89(1):35-42. PubMed ID: 21075144
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus infection by polyoxometalates.
Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
[TBL] [Abstract][Full Text] [Related]
20. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
